Correlation Between Biora Therapeutics and HCW Biologics
Can any of the company-specific risk be diversified away by investing in both Biora Therapeutics and HCW Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biora Therapeutics and HCW Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biora Therapeutics and HCW Biologics, you can compare the effects of market volatilities on Biora Therapeutics and HCW Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biora Therapeutics with a short position of HCW Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biora Therapeutics and HCW Biologics.
Diversification Opportunities for Biora Therapeutics and HCW Biologics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Biora and HCW is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Biora Therapeutics and HCW Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HCW Biologics and Biora Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biora Therapeutics are associated (or correlated) with HCW Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HCW Biologics has no effect on the direction of Biora Therapeutics i.e., Biora Therapeutics and HCW Biologics go up and down completely randomly.
Pair Corralation between Biora Therapeutics and HCW Biologics
Given the investment horizon of 90 days Biora Therapeutics is expected to under-perform the HCW Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Biora Therapeutics is 2.84 times less risky than HCW Biologics. The stock trades about -0.11 of its potential returns per unit of risk. The HCW Biologics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 211.00 in HCW Biologics on September 2, 2024 and sell it today you would lose (164.00) from holding HCW Biologics or give up 77.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biora Therapeutics vs. HCW Biologics
Performance |
| Timeline |
| Biora Therapeutics |
| HCW Biologics |
Biora Therapeutics and HCW Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biora Therapeutics and HCW Biologics
The main advantage of trading using opposite Biora Therapeutics and HCW Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biora Therapeutics position performs unexpectedly, HCW Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HCW Biologics will offset losses from the drop in HCW Biologics' long position.| Biora Therapeutics vs. Enveric Biosciences | Biora Therapeutics vs. Elevation Oncology | Biora Therapeutics vs. Hepion Pharmaceuticals | Biora Therapeutics vs. Zura Bio Limited |
| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |